Skip to main content
Top
Published in: Health Economics Review 1/2015

Open Access 01-12-2015 | Research

A reconstruction of a medical history from administrative data: with an application to the cost of skin cancer

Authors: David Rowell, Louisa G Gordon, Catherine M Olsen, David C Whiteman

Published in: Health Economics Review | Issue 1/2015

Login to get access

Abstract

The medical record is a repository of clinical data, which can greatly enhance the quality of health and healthcare analysis. Administrative data are collected for the purpose of billing and reimbursement, and are valued by health researchers because the data are routinely audited to maintain accurate financial records. However, the quantity of incorporated clinical data can be variable. In this paper we reconstruct the medical record from health service invoices to estimate the cost of treating keratinocytic cancer (KC). The data from an epidemiological survey were linked to an administrative data set supplied by the national health insurer. A matched sampling technique with multivariable analysis was used to estimate cost. A KC treatment was identified with 42 service codes which explicitly nominated treatment of a KC. Algorithms identifying comorbities potentially correlated with KC were constructed from the service codes. The annual cost of a KC treatment was estimated to be AU$667 per individual. The average cost of explicit KC treatments was AU$231, while the cost of generic procedures used to treat KC was AU$436. Our ability to accurately control for the medical history enabled our analysis to quantify and describe the constituent costs of KC treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ayanian J. Using administrative data to assess health care outcomes. Eur Heart J. 1999;20(23):1689–91.CrossRefPubMed Ayanian J. Using administrative data to assess health care outcomes. Eur Heart J. 1999;20(23):1689–91.CrossRefPubMed
2.
go back to reference Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed
3.
go back to reference Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009;47(7_Supplement_1):S51–S5.CrossRefPubMed Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009;47(7_Supplement_1):S51–S5.CrossRefPubMed
4.
go back to reference Lomas A, Leonardi‐Bee J, Bath‐Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–80.CrossRefPubMed Lomas A, Leonardi‐Bee J, Bath‐Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–80.CrossRefPubMed
5.
go back to reference Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184(1):6–10.PubMed Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184(1):6–10.PubMed
6.
go back to reference Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5):774–8.CrossRefPubMed Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5):774–8.CrossRefPubMed
7.
go back to reference Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust. 2012;197(10):565–8.CrossRefPubMed Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust. 2012;197(10):565–8.CrossRefPubMed
8.
go back to reference Housman TS, Feldman SR, Williford PM, Fleischer Jr AB, Goldman ND, Acostamadiedo JM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48(3):425–9.CrossRefPubMed Housman TS, Feldman SR, Williford PM, Fleischer Jr AB, Goldman ND, Acostamadiedo JM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48(3):425–9.CrossRefPubMed
9.
go back to reference Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, et al. Non-Melanoma skin cancer incidence and impact of skin cancer screening on incidence. Journal of Investigative Dermatology. 2013. Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, et al. Non-Melanoma skin cancer incidence and impact of skin cancer screening on incidence. Journal of Investigative Dermatology. 2013.
10.
go back to reference Nilsson GH, Carlsson L, Dal H, Ullen H. Skin diseases caused by ultraviolet radiation: the cost of illness. Int J Technol Assess Health Care. 2003;19(4):724–30.CrossRefPubMed Nilsson GH, Carlsson L, Dal H, Ullen H. Skin diseases caused by ultraviolet radiation: the cost of illness. Int J Technol Assess Health Care. 2003;19(4):724–30.CrossRefPubMed
11.
go back to reference Tinghog G, Carlsson P, Synnerstad I, Rosdahl I. Societal cost of skin cancer in Sweden in 2005. Acta Derm Venereol. 2008;88(5):467–73.CrossRefPubMed Tinghog G, Carlsson P, Synnerstad I, Rosdahl I. Societal cost of skin cancer in Sweden in 2005. Acta Derm Venereol. 2008;88(5):467–73.CrossRefPubMed
12.
go back to reference Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65–72.PubMed Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65–72.PubMed
13.
go back to reference Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008;100(17):1215–22.CrossRefPubMedCentralPubMed Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008;100(17):1215–22.CrossRefPubMedCentralPubMed
14.
go back to reference Rogers HW, Coldiron BM. Analysis of skin cancer treatment and costs in the United States medicare population, 1996–2008. Dermatol Surg. 2013;39(1pt1):35–42.CrossRefPubMed Rogers HW, Coldiron BM. Analysis of skin cancer treatment and costs in the United States medicare population, 1996–2008. Dermatol Surg. 2013;39(1pt1):35–42.CrossRefPubMed
15.
go back to reference Souza RJ, Mattedi AP, Correa MP, Rezende ML, Ferreira AC. An estimate of the cost of treating non-melanoma skin cancer in the state of Sao Paulo, Brazil. An Bras Dermatol. 2011;86(4):657–62.CrossRefPubMed Souza RJ, Mattedi AP, Correa MP, Rezende ML, Ferreira AC. An estimate of the cost of treating non-melanoma skin cancer in the state of Sao Paulo, Brazil. An Bras Dermatol. 2011;86(4):657–62.CrossRefPubMed
16.
go back to reference Bentzen J, Kjellberg J, Thorgaard C, Engholm G, Phillip A, Storm HH. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark. Eur J Cancer Prev. 2013;22(6):569–76.CrossRefPubMed Bentzen J, Kjellberg J, Thorgaard C, Engholm G, Phillip A, Storm HH. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark. Eur J Cancer Prev. 2013;22(6):569–76.CrossRefPubMed
17.
go back to reference Souza RJ, Mattedi AP, Rezende ML, Correa Mde P, Duarte EM. An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil. An Bras Dermatol. 2009;84(3):237–43.CrossRefPubMed Souza RJ, Mattedi AP, Rezende ML, Correa Mde P, Duarte EM. An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil. An Bras Dermatol. 2009;84(3):237–43.CrossRefPubMed
18.
go back to reference Chen JG, Fleischer AB, Smith ED, Kancler C, Goldman ND, Williford PM, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035–8.PubMed Chen JG, Fleischer AB, Smith ED, Kancler C, Goldman ND, Williford PM, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035–8.PubMed
19.
go back to reference Olsen CM, Green AC, Neale RE, Webb PM, Cicero RA, Jackman LM, et al. Cohort profile: the QSkin sun and health study. Int J Epidemiol. 2012;41(4):929-i.CrossRef Olsen CM, Green AC, Neale RE, Webb PM, Cicero RA, Jackman LM, et al. Cohort profile: the QSkin sun and health study. Int J Epidemiol. 2012;41(4):929-i.CrossRef
20.
go back to reference Morze CJ, Olsen CM, Perry SL, Jackman LM, Ranieri BA, O’Brien SM, et al. Good test–retest reproducibility for an instrument to capture self-reported melanoma risk factors. J Clin Epidemiol. 2012;65(12):1329–36.CrossRefPubMed Morze CJ, Olsen CM, Perry SL, Jackman LM, Ranieri BA, O’Brien SM, et al. Good test–retest reproducibility for an instrument to capture self-reported melanoma risk factors. J Clin Epidemiol. 2012;65(12):1329–36.CrossRefPubMed
21.
go back to reference National Cancer Control Initiative. The 2002 National Non-Melanoma Skin Cancer Survey. A report by the NCCI Non-Melanoma Skin Cancer Working Group. Edited by MP Staples. Melbourne: NCCI; 2003. National Cancer Control Initiative. The 2002 National Non-Melanoma Skin Cancer Survey. A report by the NCCI Non-Melanoma Skin Cancer Working Group. Edited by MP Staples. Melbourne: NCCI; 2003.
22.
go back to reference Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1686–95.CrossRefPubMed Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1686–95.CrossRefPubMed
23.
go back to reference Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(20):3099–112.CrossRefPubMed Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(20):3099–112.CrossRefPubMed
24.
go back to reference Australian Institute of Health and Welfare (AIHW). Health Expenditure Australia 2010–11. AIHW cat. no. HWE 56. Canberra: Australian Institute of Health and Welfare; 2011. Report No. Australian Institute of Health and Welfare (AIHW). Health Expenditure Australia 2010–11. AIHW cat. no. HWE 56. Canberra: Australian Institute of Health and Welfare; 2011. Report No.
25.
go back to reference Cristofolini M, Bianchi R, Boi S, Decarli A, Hanau C, Micciolo R, et al. Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer. 1993;71(2):370–4.CrossRefPubMed Cristofolini M, Bianchi R, Boi S, Decarli A, Hanau C, Micciolo R, et al. Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer. 1993;71(2):370–4.CrossRefPubMed
26.
go back to reference Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust. 2012;196(11):686–7.CrossRefPubMed Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust. 2012;196(11):686–7.CrossRefPubMed
27.
go back to reference Scragg R, Holdaway I, Jackson R, Lim T. Plasma 25-hydroxyvitamin D and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol. 1992;2(5):697–703.CrossRefPubMed Scragg R, Holdaway I, Jackson R, Lim T. Plasma 25-hydroxyvitamin D and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol. 1992;2(5):697–703.CrossRefPubMed
28.
go back to reference Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2010;128(6):1414–24.CrossRef Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2010;128(6):1414–24.CrossRef
29.
go back to reference van der Mei PDI. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007;254(5):581–90.CrossRefPubMed van der Mei PDI. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007;254(5):581–90.CrossRefPubMed
30.
go back to reference Avenell A, Gillespie W, Gillespie L, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. ACP J Club. 2006;144(1):14. Avenell A, Gillespie W, Gillespie L, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. ACP J Club. 2006;144(1):14.
32.
go back to reference Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metabol. 2010;95(7):3225–33.CrossRef Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metabol. 2010;95(7):3225–33.CrossRef
33.
go back to reference Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67(7):808.CrossRefPubMedCentralPubMed Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67(7):808.CrossRefPubMedCentralPubMed
34.
go back to reference Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113–9.CrossRefPubMed Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113–9.CrossRefPubMed
38.
go back to reference Jones AM. Models for Health Care: HEDG Working Paper 10/01York: University of York 2010.39. In: Wooldridge JM, editor. Introductory econometrics: a modern approach. USA: Southern-Western College Publishing; 2000. Jones AM. Models for Health Care: HEDG Working Paper 10/01York: University of York 2010.39. In: Wooldridge JM, editor. Introductory econometrics: a modern approach. USA: Southern-Western College Publishing; 2000.
39.
go back to reference Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–94.CrossRefPubMed Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–94.CrossRefPubMed
40.
go back to reference Mendenhall W, Reinmuth J. Statistics for Management and Economics North Scituate. Massachusetts: Duxbury Press; 1978. Mendenhall W, Reinmuth J. Statistics for Management and Economics North Scituate. Massachusetts: Duxbury Press; 1978.
41.
go back to reference Ong ELH, Goldacre R, Hoang U, Sinclair R, Goldacre M. Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study. Cancer Epidemiol Biomarkers Prev. 2014;23(3):490–8.CrossRefPubMed Ong ELH, Goldacre R, Hoang U, Sinclair R, Goldacre M. Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study. Cancer Epidemiol Biomarkers Prev. 2014;23(3):490–8.CrossRefPubMed
42.
go back to reference Ong ELH, Goldacre R, Hoang U, Sinclair R, Goldacre M. Subsequent primary malignancies in patients with nonmelanoma skin cancer in england: a national record-linkage study. Cancer Epidemiol Biomarkers Prev. 2014;23(3):490–8.CrossRefPubMed Ong ELH, Goldacre R, Hoang U, Sinclair R, Goldacre M. Subsequent primary malignancies in patients with nonmelanoma skin cancer in england: a national record-linkage study. Cancer Epidemiol Biomarkers Prev. 2014;23(3):490–8.CrossRefPubMed
Metadata
Title
A reconstruction of a medical history from administrative data: with an application to the cost of skin cancer
Authors
David Rowell
Louisa G Gordon
Catherine M Olsen
David C Whiteman
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Health Economics Review / Issue 1/2015
Electronic ISSN: 2191-1991
DOI
https://doi.org/10.1186/s13561-015-0042-x

Other articles of this Issue 1/2015

Health Economics Review 1/2015 Go to the issue